[Multidisciplinary treatment in the long-term management of Fabry disease].

Abstract excerpt

Fabry disease is a rare X-linked hereditary condition caused by mutations in the α-galactosidase A (GLA) gene, resulting in decreased α-GAL A enzyme activity. The clinical manifestations of Fabry disease are diverse, which leads to delays in diagnosis and treatment, thereby increasing the disease burden for patients and their families. Given its characteristics, multidisciplinary treatment (MDT) is critical for...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to alpha-Galactosidase
• Share to Child
• Share to Enzyme Replacement Therapy